TGF‐β1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors
暂无分享,去创建一个
[1] M. Reed,et al. Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[2] T. McCaffrey,et al. Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-beta in vascular smooth muscle cells. , 1993, Molecular biology of the cell.
[3] E. Sage,et al. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts , 1993, Journal of cellular physiology.
[4] K. Takeda,et al. Similar, but not identical, modulation of expression of extracellular matrix components during in vitro and in vivo aging of human skin fibroblasts , 1992, Journal of cellular physiology.
[5] M. Sporn,et al. Transforming growth factor-beta: recent progress and new challenges. , 1992 .
[6] E. Ruoslahti,et al. Transforming growth factor-beta in disease: the dark side of tissue repair. , 1992, The Journal of clinical investigation.
[7] G F Pierce,et al. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. , 1992, The American journal of pathology.
[8] S. Weinstein,et al. Age‐related changes in hyaluronan, proteoglycan, collagen, and osteonectin synthesis by human bone cells , 1992, Journal of cellular physiology.
[9] E. Sage,et al. Expression of SPARC is correlated with altered morphologies in transfected F9 embryonal carcinoma cells. , 1992, Experimental cell research.
[10] R. Ross,et al. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[11] D. Foreman,et al. Control of scarring in adult wounds by neutralising antibody to transforming growth factor β , 1992, The Lancet.
[12] P. Bornstein,et al. Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin. , 1991, The Journal of biological chemistry.
[13] A. Lambowitz,et al. Diverse gene sequences are overexpressed in werner syndrome fibroblasts undergoing premature replicative senescence , 1991, Molecular and cellular biology.
[14] P. Hanawalt,et al. Direct evidence for spatial and temporal regulation of transforming growth factor β1 expression during cutaneous wound healing , 1991, Journal of cellular physiology.
[15] M. Iruela-Arispe,et al. Modulation of extracellular matrix proteins by endothelial cells undergoing angiogenesis in vitro. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[16] J. Davidson,et al. Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: incisional wound model. , 1991, The Journal of investigative dermatology.
[17] R. McAnulty,et al. Age-related changes in collagen synthesis and degradation in rat tissues. Importance of degradation of newly synthesized collagen in regulating collagen production. , 1991, The Biochemical journal.
[18] Thomas A. Mustoe, MD, FACS,et al. Quantitative analysis of inflammatory cell influx, procollagen type I synthesis, and collagen cross-linking in incisional wounds: influence of PDGF-BB and TGF-beta 1 therapy. , 1991, The Journal of laboratory and clinical medicine.
[19] E. Sage,et al. The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Wrana,et al. Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor beta. Comparison of transcriptional and post-transcriptional control with fibronectin and type I collagen. , 1991, European journal of biochemistry.
[21] E. Vuorio,et al. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea. , 1991, The Journal of rheumatology.
[22] M. Iruela-Arispe,et al. Differential expression of extracellular proteins is correlated with angiogenesis in vitro. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[23] J. Termine. Cellular activity, matrix proteins, and aging bone , 1990, Experimental Gerontology.
[24] M. Martin,et al. Fibronectin and collagen gene expression during in vitro ageing of pig skin fibroblasts. , 1990, Experimental cell research.
[25] Harold L. Moses,et al. TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights , 1990, Cell.
[26] P. Canney,et al. Transforming growth factor beta: a promotor of late connective tissue injury following radiotherapy? , 1990, The British journal of radiology.
[27] J. R. Smith,et al. Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. , 1989, Experimental cell research.
[28] E. A. Everitt,et al. SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix , 1989, The Journal of cell biology.
[29] H. Sage,et al. The calcium-binding protein SPARC is secreted by Leydig and Sertoli cells of the adult mouse testis. , 1989, Biology of reproduction.
[30] M. Iruela-Arispe,et al. Distribution of the calcium-binding protein SPARC in tissues of embryonic and adult mice. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[31] Thomas A. Mustoe, MD, FACS,et al. Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[32] S. Funk,et al. SPARC: a Ca2+-binding extracellular protein associated with endothelial cell injury and proliferation. , 1989, Journal of molecular and cellular cardiology.
[33] L Orci,et al. Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[34] P. Bornstein,et al. Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[35] V. Duance,et al. Type I and III collagen content and fibre distribution in normal human skin during ageing , 1987, The British journal of dermatology.
[36] J. Heath,et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. , 1987, The EMBO journal.
[37] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[38] H. Moses,et al. Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. , 1987, The Journal of clinical investigation.
[39] B. Hogan,et al. Evidence from molecular cloning that SPARC, a major product of mouse embryo parietal endoderm, is related to an endothelial cell ‘culture shock’ glycoprotein of Mr 43,000. , 1986, The EMBO journal.
[40] B. Gilchrest,et al. Growth factor responsiveness declines during adulthood for human skin-derived cells , 1986, Mechanisms of Ageing and Development.
[41] M. Sporn,et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[42] J. Massagué,et al. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.
[43] T. Ide,et al. Loss of responsiveness in senescent human TIG-1 cells to the DNA synthesis-inducing effect of various growth factors , 1984, Mechanisms of Ageing and Development.
[44] B. Gilchrest,et al. Growth factor responsiveness of cultured human fibroblasts declines with age. , 1983, Journal of gerontology.
[45] J. Myers,et al. Cloning and characterization of five overlapping cDNAs specific for the human pro alpha 1(I) collagen chain. , 1982, Nucleic acids research.
[46] H. Kleinman,et al. Osteonectin, a bone-specific protein linking mineral to collagen , 1981, Cell.
[47] C. Harley,et al. Decreased sensitivity of old and progeric human fibroblasts to a preparation of factors with insulinlike activity. , 1981, The Journal of clinical investigation.
[48] S. Shuster,et al. The influence of age and sex on skin thickness, skin collagen and density , 1975, The British journal of dermatology.
[49] V. J. Selmanowitz,et al. SECTION OF BIOLOGICAL AND MEDICAL SCIENCES: LEVELS OF BIOLOGICAL FUNCTIONS WITH AGING* , 1969 .
[50] F. Greenwood,et al. Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity , 1962, Nature.
[51] H. Goldberg,et al. Immunohistochemical localization of SPARC (osteonectin) and denatured collagen and their relationship to remodelling in rat dental tissues. , 1990, Archives of oral biology.
[52] V. Cristofalo,et al. Progressive loss of the proliferative response of senescing WI-38 cells to platelet-derived growth factor, epidermal growth factor, insulin, transferrin, and dexamethasone. , 1984, Journal of gerontology.
[53] E. Schneider,et al. Skin fibroblast cultures derived from members of the Baltimore longitudinal study: a new resource for studies of cellular aging. , 1981, Cytogenetics and cell genetics.
[54] J. Uitto,et al. Protocollagen proline hydroxylase activity in the skin of normal human subjects and of patients with scleroderma. , 1969, Scandinavian journal of clinical and laboratory investigation.